Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC studyAl Ozonoff, Brenda Barton, Joanna Schaenman et al.|Nature Communications|2024Cited by 58
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trialAngela R Branche, Kuleni Abebe, Nadine Rouphael et al.|Nature Medicine|2023Cited by 56
SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary AnalysesAngela R Branche, Kuleni Abebe, Nadine Rouphael et al.|medRxiv|2022Cited by 30
Persistent SARS-CoV-2–specific immune defects in kidney transplant recipients following third mRNA vaccine doseWilliam A. Werbel, Dorry L. Segev, Andrew H. Karaba et al.|American Journal of Transplantation|2023Cited by 19
Heterologous versus homologous boosting elicits qualitatively distinct, BA.5–cross-reactive T cells in transplant recipientsElizabeth A. Thompson, Andrea L. Cox, Wabathi Ngecu et al.|JCI Insight|2023Cited by 11